State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine

Molecular Pharmacology

Volumn 73, Issue 3, 2008, Pages 940-948

  Ging, Kuo Wang ^a   Calderon, Joanna ^a   Wang, Sho Ya ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANOLAZINE; VOLTAGE GATED SODIUM CHANNEL;

ARTICLE; CELL LINE; DRUG BLOOD LEVEL; DRUG MECHANISM; EMBRYO; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING;

ACETANILIDES; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; HUMANS; INHIBITORY CONCENTRATION 50; ION CHANNEL GATING; KIDNEY; KINETICS; MOLECULAR STRUCTURE; MUSCLE PROTEINS; MUSCLES; MUTATION; NEURONS; PATCH-CLAMP TECHNIQUES; PIPERAZINES; PROTEIN ISOFORMS; RECOMBINANT PROTEINS; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; TRANSFECTION;

EID: 40849140980     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.041541     Document Type: Article

References (32)

1. Aldrich RW, Corey DP, and Stevens CF (1983) A reinterpretation of mammalian sodium channel gating based on single channel recording. Nature 306:436-441.
2. Antzelevitch C, Belardinelli L, Wu L, Fraser H, Zygmunt AC, Burashnikov A, Diego JM, Fish JM, Cordeiro JM, Goodrow RJ Jr, et al. (2004) Electrophysiologic properties and antiarrhythmic actions of a novel antianginal agent. J Cardiovasc Pharmacol Ther 9 Suppl 1:S65-S83.
3. + channels, in Ion Channels and Disease, pp 67-96, Academic Press, London.
4. Belardinelli L, Shryock JC, and Fraser H (2006) Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine. Heart 92 Suppl 4:iv6-iv14.
5. Burashnikov A, Di Diego JM, Zygmunt AC, Belardinelli L, and Antzelevitch C (2007) Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine. Circulation 116:1449-1457.
6. Cannon SC (1996) Ion-channel defects and aberrant excitability in myotonia and periodic paralysis. Trends in Neurosci 19:3-10.
7. Catterall WA and Mackie K (2001) Local anesthetics, in Goodman & Gilman's The Pharmacological Basis of Therapeutics (Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, and Gilman AG eds) pp 367-384, Macmillan Publishing Company, New York.
8. Chaitman BR (2006) Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. Circulation 113:2462-2472.
9. Cota G and Armstrong CM (1989) Sodium channel gating in clonal pituitary cells: the inactivation step is not voltage dependent. J Gen Physiol 94:213-232.
10. Edrich T, Wang SY, and Wang GK (2005) State-dependent block of human cardiac HNav1.5 sodium channels by propafenone. J Membr Biol 207:35-43.
11. Fredj S, Sampson KJ, Liu H, and Kass RS (2006) Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action. Br J Pharmacol 148:16-24.
12. George AL Jr (2005) Inherited disorders of voltage-gated sodium channels. J Clin Invest 115:1990-1999.
13. Goldin AL (2001) Resurgence of sodium channel research. Annu Rev Physiol 63:871-894.
14. Hamill OP, Marty E, Neher ME, Sakmann B, and Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391:85-100.
15. Hille B (2001) Classical mechanisms of block, in Ion Channels of Excitable Membranes, pp 503-536, Sinauer Associates Inc., Sunderland, MA.
16. Hille B (1977) Local anesthetics: hydrophilic and hydrophobic pathways for the drug receptor reaction. J Gen Physiol 69:497-515.
17. Klugbauer N, Lacinova L, Flockerzi V, and Hofmann F (1995) Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells. EMBO J 14:1084-1090.
18. McNulty MM, Edgerton GB, Shah RD, Hanck DA, Fozzard HA, and Lipkind GM (2007) Charge at the lidocaine binding site residue phe-1759 affects permeation in human cardiac voltage-gated sodium channels. J Physiol 581:741-755.
19. Nassar MA, Stirling LC, Forlani G, Baker MD, Matthews EA, Dickenson AH, and Wood JN (2004) Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. Proc Natl Acad Sci U S A 101:12706-12711.
20. + channels. J Membr Biol 201:1-8.
21. Noble D and Noble PJ (2006) Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload. Heart 92 Suppl 4:iv1-iv5.
22. Pepine CJ and Wolff AA (1999) A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents. Ranolazine Study Group. Am J Cardiol 84:46-50.
23. + channels by local anesthetics. Science 265:1724-1728.
24. Ramos E and O'leary ME (2004) State-dependent trapping of flecainide in the cardiac sodium channel. J Physiol 560:37-49.
25. Schram G, Zhang L, Derakhchan K, Ehrlich JR, Belardinelli L, and Nattel S (2004) Ranolazine: ion-channel-blocking actions and in vivo electrophysiological effects. Br J Pharmacol 142:1300-1308.
26. Na in guinea pig ventricular myocytes. J Cardiovasc Pharmacol 44:192-199.
27. + channels by flecainide. J Gen Physiol 122:365-374.
28. Wang S-Y, Bonner K, Russell C, and Wang GK (2003b) Tryptophan scanning of D1S6 and D4S6 C-termini in voltage-gated Sodium Channels. Biophys J 85:911-920.
29. + channels by local anesthetics in stably transfected mammalian cells: evidence for drug binding along the activation pathway. J Gen Physiol 124:691-701.
30. Wood JN and Baker M (2001) Voltage-gated sodium channels. Curr Opin Pharmacol 1:17-21.
31. Wood JN, Boorman JP, Okuse K, and Baker MD (2004) Voltage-gated sodium channels and pain pathways. J Neurobiol 61:55-71.
32. Wright SN, Wang S-Y, Kallen RG, and Wang GK (1997) Differences in steady-state inactivation between Na channel isoforms affect local anesthetic binding affinity. Biophys J 73:779-788.